-
1
-
-
34548155658
-
Which domains of thyroid-related quality of life are most relevant?
-
Watt T, Hegedus L, Rasmussen AK et al. Which domains of thyroid-related quality of life are most relevant? Thyroid 2007;17:647-54.
-
(2007)
Thyroid
, vol.17
, pp. 647-654
-
-
Watt, T.1
Hegedus, L.2
Rasmussen, A.K.3
-
2
-
-
33646035188
-
Quality of life in patients with benign thyroid disorders
-
Watt T, Groenvold M, Rasmussen AK et al. Quality of life in patients with benign thyroid disorders. Eur J Endocrinol 2006;154:501-10.
-
(2006)
Eur J Endocrinol
, vol.154
, pp. 501-510
-
-
Watt, T.1
Groenvold, M.2
Rasmussen, A.K.3
-
3
-
-
0036299579
-
Long-term effects of Graves' ophthalmopathy on health-related quality of life
-
Terwee C, Wakelkamp I, Tan S et al. Long-term effects of Graves' ophthalmopathy on health-related quality of life. Eur J Endocrinol 2002;146:751-7.
-
(2002)
Eur J Endocrinol
, vol.146
, pp. 751-757
-
-
Terwee, C.1
Wakelkamp, I.2
Tan, S.3
-
4
-
-
1542345596
-
Health-related quality of life in patients with thyroid disorders
-
Bianchi GP, Zaccheroni V, Solaroli E et al. Health-related quality of life in patients with thyroid disorders. Qual Life Res 2004;13:45-54.
-
(2004)
Qual Life Res
, vol.13
, pp. 45-54
-
-
Bianchi, G.P.1
Zaccheroni, V.2
Solaroli, E.3
-
6
-
-
29244465086
-
Graves' disease: A long-term quality-of-life follow up of patients randomized to treatment with antithyroid drugs, radioiodine, or surgery
-
Abraham-Nordling M, Torring O, Hamberger B et al. Graves' disease: a long-term quality-of-life follow up of patients randomized to treatment with antithyroid drugs, radioiodine, or surgery. Thyroid 2005;15:1279-86.
-
(2005)
Thyroid
, vol.15
, pp. 1279-1286
-
-
Abraham-Nordling, M.1
Torring, O.2
Hamberger, B.3
-
7
-
-
18744419707
-
Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism
-
Bunevicius R, Kazanavicius G, Zalinkevicius R et al. Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism. N Engl J Med 1999;340:424-9.
-
(1999)
N Engl J Med
, vol.340
, pp. 424-429
-
-
Bunevicius, R.1
Kazanavicius, G.2
Zalinkevicius, R.3
-
8
-
-
34548291456
-
Treatment of clinical hypothyroidism with thyroxine and triiodothyronine
-
Joffe RT, Brimacombe M, Levitt AJ et al. Treatment of clinical hypothyroidism with thyroxine and triiodothyronine. Psychosomatics 2007;48:379-84.
-
(2007)
Psychosomatics
, vol.48
, pp. 379-384
-
-
Joffe, R.T.1
Brimacombe, M.2
Levitt, A.J.3
-
9
-
-
34249854618
-
The beneficial effect of L-thyroxine on cardiovascular risk factors, endothelial function, and quality of life in subclinical hypothyroidism
-
Razvi S, Ingoe L, Keeka G et al. The beneficial effect of L-thyroxine on cardiovascular risk factors, endothelial function, and quality of life in subclinical hypothyroidism. J Clin Endocrinol Metab 2007;92:1715-23.
-
(2007)
J Clin Endocrinol Metab
, vol.92
, pp. 1715-1723
-
-
Razvi, S.1
Ingoe, L.2
Keeka, G.3
-
10
-
-
42749098792
-
Guidance for Industry. Patient-reported outcome measures: Use in medical product development to support labeling claims (draft)
-
and Drug administration
-
US Food and Drug administration. Guidance for Industry. Patient-reported outcome measures: use in medical product development to support labeling claims (draft). Health and Quality of Life Outcomes 2006;4.
-
(2006)
Health and Quality of Life Outcomes
, pp. 4
-
-
Food, U.S.1
|